Refinements in managing maternal weight adjustment for interpreting prenatal screening results

Prenatal Diagnosis

Volumn 16, Issue 12, 1996, Pages 1115-1119

  Neveux, Louis M ^a   Palomaki, Glenn E ^a   Larrivee, David A ^a   Knight, George J ^a   Haddow, James E ^a  

^a FOUNDATION FOR BLOOD RESEARCH   (United States)

Author keywords

Adjustment; Alpha fetoprotein; Human chorionic gonadotropin; Maternal weight; Prenatal screening; Unconjugated oestriol

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; ESTRIOL;

ARTICLE; BLOOD LEVEL; BODY WEIGHT; DIAGNOSTIC ACCURACY; DOWN SYNDROME; ESTRIOL BLOOD LEVEL; FEMALE; GONADOTROPIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; NEURAL TUBE DEFECT; NORMAL HUMAN; NORMAL VALUE; PRENATAL SCREENING; PRIORITY JOURNAL;

ALPHA-FETOPROTEINS; BODY WEIGHT; CHORIONIC GONADOTROPIN; DOWN SYNDROME; ESTRIOL; FEMALE; HUMANS; MATHEMATICS; NEURAL TUBE DEFECTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; RISK FACTORS;

EID: 0030457481     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6     Document Type: Article

References (7)

1. Dixon, W.J. (Ed.) (1992). BMDP Statistical Software Manual, Berkeley, CA: University of California Press.
2. Haddow, J.E., Palomaki, G.E., Knight, G.J., Williams, J., Pulkkinen, A., Canick, J.A., Saller, D.N., Barsel-Bowers, G. (1992). Prenatal screening for Down's syndrome with use of maternal serum markers, N. Engl. J. Med., 327, 588-593.
3. Johnson, A.M., Palomaki, G.E., Haddow, J.E. (1990). The effect of adjusting maternal serum α-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida, Am. J. Obstet. Gynecol., 163, 9-11.
4. Palomaki, G.E., Panizza, D.S., Canick, J.A. (1990). Screening for Down syndrome using AFP, uE3 and hCG: effect of maternal weight, Am. J. Hum. Genet., 7, a282.
5. Palomaki, G.E., Knight, G.J., Haddow, J.E., Canick, J.A., Saller, D.N., Panizza, D.S. (1992). Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin, Prenat. Diagn., 12, 925-930.
6. Palomaki, G.E., Haddow, J.E., Knight, G.J., Wald, N.J., Kennard, A., Canick, J.A., Saller, D.N., Blitzer, M.G., Dickerman, L.H., Fisher, R., Hansmann, D., Hansmann, M., Luthy, D.A., Summers, A.M., Wyatt, P. (1995). Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin, Prenat. Diagn., 15, 713-723.
7. Wald, N.J., Cuckle, H.S., Densem, J.W., Kennard, A., Smith, D. (1992). Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight, Br. J. Obstet. Gynaecol., 99, 144-149.